Abstract
Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
J Itoh, M Ukai and T Kameyama
Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;